References: 1. Holly FJ. Lacrophilic ophthalmic demulcents. US Ophthalmic Rev. 2007;3:38-41. 2. FRESHKOTE Drug Facts. Eyevance Pharmaceuticals LLC; 2018. 3. Holly FJ.
Colloidal Osmosis — Oncotic Pressure. Grapevine, TX: Dry Eye Institute; 2006. 4. Fuller DG, Connor CG. Safety and e‹ cacy of FreshKote
®
used as a rewetting agent in Lotra' lcon-A
®
contact lens wearers. Poster presented at: American Academy of Optometry Annual Meeting; November 17-20, 2010; San Francisco, CA. 5. Nemera. Novelia
®
. https://nemera.net/
products/ophthalmic-novelia-eyedropper/. Accessed March 14, 2019.
nurture
Take a fresh approach to treating dry eye symptoms
with FRESHKOTE
®
Preservative Free (PF)
Patented polymer blend of polyvinyl alcohol and povidone supports
all layers of the tear ' lm
1,2
Triple-acting formula reduces evaporation and increases stability of
the tear ' lm while high oncotic pressure reduces epithelial cell swelling
1,3
Compatible for use with contact lenses
4
State-of-the-art multidose bottle provides more than a month's worth
of preservative-free drops when dosed 4 times a day
5
Stop by EYEVANCE BOOTH #1106 during AOA 2019.
R E C O M M E N D S O OT H I N G R E L I E F
Visit FRESHKOTEPF.com to learn more
© 2019 Eyevance Pharmaceuticals LLC. All rights reserved.
FRESHKOTE® is a registered trademark of Eyevance Pharmaceuticals LLC.
Novelia is a registered trademark of Nemera Development.
FPF-19-AD-19-00
